Surgical management of insulinomas: Short- and long-term outcomes after enucleations and pancreatic resections

Archives of Surgery

Volumn 147, Issue 3, 2012, Pages 261-266

  Crippa, Stefano ^a,c   Zerbi, Alessandro ^b,d   Boninsegna, Letizia ^a,c   Capitanio, Vanessa ^b   Partelli, Stefano ^a,c   Balzano, Gianpaolo ^b   Pederzoli, Paolo ^a   Di Carlo, Valerio ^b   Falconi, Massimo ^a,c  

^a UNIVERSITY OF VERONA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUCOSE;

ADOLESCENT; ADRENALECTOMY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCRINE TUMOR; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINISM; INSULINOMA; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; ONSET AGE; PANCREAS EXOCRINE INSUFFICIENCY; PANCREAS RESECTION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INSULINOMA; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84858786732     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.1843     Document Type: Article

References (43)

1. Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin NorthAm. 2009;89(5):1105-1121.
2. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg. 2006;93(3):264-275.
3. de Herder WW, Niederle B, Scoazec JY, et al; Frascati Consensus Conference; European Neuroendocrine Tumor Society. Well-differentiated pancreatic tumor/ carcinoma: insulinoma. Neuroendocrinology. 2006;84(3):183-188.
4. Davì MV, Boninsegna L, Dalle Carbonare L, et al. Presentation and outcome of pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 syndrome. Neuroendocrinology. 2011;94(1):58-65.
5. Nikfarjam M, Warshaw AL, Axelrod L, et al. Improved contemporary surgical management of insulinomas: a 25-year experience at the Massachusetts General Hospital. Ann Surg. 2008;247(1):165-172.
6. Lo CY, Lam KY, Fan ST. Surgical strategy for insulinomas in multiple endocrine neoplasia type I. Am J Surg. 1998;175(4):305-307.
7. Hashimoto LA, Walsh RM. Preoperative localization of insulinomas is not necessary. J Am Coll Surg. 1999;189(4):368-373. (Pubitemid 29455676)
8. Norton JA, Shawker TH, Doppman JL, et al. Localization and surgical treatment of occult insulinomas. Ann Surg. 1990;212(5):615-620.
9. Hirshberg B, Libutti SK, Alexander HR, et al. Blind distal pancreatectomy for occult insulinoma, an inadvisable procedure. J Am Coll Surg. 2002;194(6): 761-764. (Pubitemid 34633639)
10. Owen NJ, Sohaib SA, Peppercorn PD, et al. MRI of pancreatic neuroendocrine tumours. Br J Radiol. 2001;74(886):968-973. (Pubitemid 33064646)
11. McLean AM, Fairclough PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab. 2005;19(2): 177-193. (Pubitemid 40347810)
12. Anderson MA, Carpenter S, Thompson NW, Nostrant TT, Elta GH, Scheiman JM. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol. 2000;95 (9):2271-2277.
13. Wiesli P, Brändle M, Schmid C, et al. Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations. J Vasc Interv Radiol. 2004;15(11):1251-1256. (Pubitemid 39487855)
14. Jackson JE. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2005;19(2):229-239. (Pubitemid 40347813)
15. Hiramoto JS, Feldstein VA, LaBerge JM, Norton JA. Intraoperative ultrasound and preoperative localization detects all occult insulinomas; discussion 1025-6. Arch Surg. 2001;136(9):1020-1025.
16. Fidler JL, Fletcher JG, Reading CC, et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. AJR Am J Roentgenol. 2003;181(3):775-780. (Pubitemid 37021854)
17. Horton KM, Hruban RH, Yeo C, Fishman EK. Multi-detector row CT of pancreatic islet cell tumors. Radiographics. 2006;26(2):453-464. (Pubitemid 43515317)
18. Norton JA. Intraoperative methods to stage and localize pancreatic and duodenal tumors. Ann Oncol. 1999;10(suppl 4):182-184.
19. Crippa S, Bassi C, Salvia R, Falconi M, Butturini G, Pederzoli P. Enucleation of pancreatic neoplasms. Br J Surg. 2007;94(10):1254-1259. (Pubitemid 47584775)
20. Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P. Pancreatic insufficiency after different resections for benign tumours. Br J Surg. 2008; 95(1):85-91. (Pubitemid 351184919)
21. Placzkowski KA, Vella A, Thompson GB, et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007. J Clin Endocrinol Metab. 2009;94(4):1069-1073.
22. Goh BKP, Ooi LL, Cheow PC, et al. Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Surg. 2009;13(6):1071-1077.
23. Lo CY, Lam KY, Kung AW, Lam KS, Tung PH, Fan ST. Pancreatic insulinomas: a 15-year experience. Arch Surg. 1997;132(8):926-930. (Pubitemid 27344148)
24. Boukhman MP, Karam JH, Shaver J, Siperstein AE, Duh QY, Clark OH. Insulinoma: experience from 1950 to 1995. West J Med. 1998;169(2):98-104.
25. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658- 5671. (Pubitemid 33152604)
26. Crippa S, Bassi C, Warshaw AL, et al. Middle pancreatectomy: indications, shortand long-term operative outcomes. Ann Surg. 2007;246(1):69-76. (Pubitemid 47012209)
27. Bassi C, Dervenis C, Butturini G, et al; International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8-13. (Pubitemid 40933766)
28. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014: 13-27. (Pubitemid 38594787)
29. Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010.
30. Rindi G, Klöppel G, Alhman H, et al; and all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449(4):395-401.
31. Arnold R, Chen YJ, Costa F, et al; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation. Neuroendocrinology. 2009;90(2):227-233.
32. Zhao YP, Zhan HX, Zhang TP, et al. Surgical management of patients with insulinomas: result of 292 cases in a single institution. J Surg Oncol. 2011;103 (2):169-174.
33. Rothmund M, Angelini L, Brunt LM, et al. Surgery for benign insulinoma: an international review. World J Surg. 1990;14(3):393-398, discussion 398-399.
34. Berends FJ, Cuesta MA, Kazemier G, et al. Laparoscopic detection and resection of insulinomas. Surgery. 2000;128(3):386-391.
35. Sweet MP, Izumisato Y, Way LW, Clark OH, Masharani U, Duh QY. Laparoscopic enucleation of insulinomas. Arch Surg. 2007;142(12):1202-1204, discussion 1205.
36. Vijan SS, Ahmed KA, Harmsen WS, et al. Laparoscopic vs open distal pancreatectomy: a single-institution comparative study. Arch Surg. 2010;145(7):616-621.
37. Cho CS, Kooby DA, Schmidt CM, et al. Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique? Ann Surg. 2011; 253(5):975-980.
38. Falconi M, Zerbi A, Crippa S, et al. Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. Ann Surg Oncol. 2010;17(6): 1621-1627.
39. Rostambeigi N, Thompson GB. What should be done in an operating room when an insulinoma cannot be found? Clin Endocrinol (Oxf) . 2009;70(4):512-515.
40. Danforth DN Jr, Gorden P, Brennan MF. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery. 1984;96(6): 1027-1037.
41. O'Riordain DS, O'Brien T, van Heerden JA, Service FJ, Grant CS. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg. 1994;18(4):488-493, discussion 493-494.
42. Demeure MJ, Klonoff DC, Karam JH, Duh QY, Clark OH. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery. 1991;110(6):998-1004, discussion 1004-1005.
43. Norton JA, Fang TD, Jensen RT. Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1. J Natl Compr Canc Netw. 2006;4(2):148-153. (Pubitemid 44265371)